HUMAN GENOME SCIENCES INC Operating Income
HUMAN GENOME SCIENCES INC reported Operating Income of -$75.19 million for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-07-26.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2012-07-26
- HUMAN GENOME SCIENCES INC operating income (loss) for the quarter ending 2012-06-30 was -$75.19M.
- HUMAN GENOME SCIENCES INC operating income (loss) for the quarter ending 2012-03-31 was -$76.18M.
- HUMAN GENOME SCIENCES INC operating income (loss) for the quarter ending 2011-12-31 was -$69.06M.
- HUMAN GENOME SCIENCES INC operating income (loss) for the quarter ending 2011-09-30 was -$76.00M.
- HUMAN GENOME SCIENCES INC operating income (loss) for fiscal 2011 was -$329.55M.
- HUMAN GENOME SCIENCES INC operating income (loss) for fiscal 2010 was -$190.77M, a 3182.95% decline from fiscal 2009.
- HUMAN GENOME SCIENCES INC operating income (loss) for fiscal 2009 was $6.19M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2012-06-30 | -$75.19M 10-Q · filed 2012-07-26 | -$151.37M 10-Q · filed 2012-07-26 | -$220.44M derived: sum of 3 quarters · filed 2012-07-26 | -$296.43M derived: sum of 4 quarters · filed 2012-07-26 |
| 2012-03-31 | -$76.18M 10-Q · filed 2012-04-26 | -$145.25M derived: sum of 2 quarters · filed 2012-04-26 | -$221.24M derived: sum of 3 quarters · filed 2012-04-26 | -$289.74M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-12-31 | -$69.06M 10-K · filed 2012-02-28 | -$145.06M derived: sum of 2 quarters · filed 2012-02-28 | -$213.55M derived: sum of 3 quarters · filed 2012-07-26 | -$329.55M 10-K · filed 2012-02-28 |
| 2011-09-30 | -$76.00M 10-K · filed 2012-02-28 | -$144.49M derived: sum of 2 quarters · filed 2012-07-26 | -$260.49M 10-Q · filed 2011-10-28 | -$336.67M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-06-30 | -$68.49M 10-Q · filed 2012-07-26 | -$184.49M 10-Q · filed 2012-07-26 | -$260.68M derived: sum of 3 quarters · filed 2012-07-26 | -$290.50M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-03-31 | -$116.00M 10-Q · filed 2012-04-26 | -$192.18M derived: sum of 2 quarters · filed 2012-04-26 | -$222.01M derived: sum of 3 quarters · filed 2012-04-26 | -$269.00M derived: sum of 4 quarters · filed 2012-04-26 |
| 2010-12-31 | -$76.18M 10-K · filed 2012-02-28 | -$106.01M derived: sum of 2 quarters · filed 2012-02-28 | -$153.00M derived: sum of 3 quarters · filed 2012-02-28 | -$190.77M 10-K · filed 2012-02-28 |
| 2010-09-30 | -$29.83M 10-K · filed 2012-02-28 | -$76.82M derived: sum of 2 quarters · filed 2012-02-28 | -$114.59M 10-Q · filed 2011-10-28 | |
| 2010-06-30 | -$46.99M 10-K · filed 2012-02-28 | -$84.77M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | -$37.77M 10-K · filed 2012-02-28 | |||
| 2009-12-31 | $6.19M 10-K · filed 2012-02-28 |